Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With Biologics to clinical practice.
In February 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a novel set of guidelines regarding the use of biologics to manage adult patients with moderate to severe psoriasis. Currently, a total of 11 biologics are approved for treatment of psoriasis, and these guidelines provide the most current evidence regarding the dosing, indications, contraindications, and adverse effects of each therapy. This review aims to present the recommendations in a form that is readily translatable to clinical practice.